172 related articles for article (PubMed ID: 10589227)
1. [Effectiveness, safety, and costs of measures for prevention of gastropathy due to the use of nonsteroidal antiinflammatory drugs].
Salentijn GJ
Ned Tijdschr Geneeskd; 1999 Nov; 143(46):2340. PubMed ID: 10589227
[No Abstract] [Full Text] [Related]
2. [Effectiveness, safety, and costs of measures for prevention of gastropathy due to the use of nonsteroidal antiinflammatory drugs].
Knol A
Ned Tijdschr Geneeskd; 1999 Nov; 143(46):2339. PubMed ID: 10589226
[No Abstract] [Full Text] [Related]
3. [Effectiveness, safety, and costs of measures for prevention of gastropathy due to the use of nonsteroidal antiinflammatory drugs].
Steen KS; Lems WF; Dijkmans BA
Ned Tijdschr Geneeskd; 1999 Aug; 143(32):1649-52. PubMed ID: 10494299
[TBL] [Abstract][Full Text] [Related]
4. Therapies for ulcers associated with nonsteroidal antiinflammatory drugs.
Weilert F; Smith AC; Stokes PL
N Engl J Med; 1998 Jul; 339(5):349; author reply 350-1. PubMed ID: 9696649
[No Abstract] [Full Text] [Related]
5. [Non-steroid gastropathy: particular features of treatment].
Vasil'ev IuV
Eksp Klin Gastroenterol; 2007; (1):56-9. PubMed ID: 17547115
[No Abstract] [Full Text] [Related]
6. [Helicobacter pylori, non-steroidal anti-inflammatory drugs and aspirin: a new piece of the puzzle].
Lesur G
Gastroenterol Clin Biol; 2001; 25(6-7):725-6. PubMed ID: 11688500
[No Abstract] [Full Text] [Related]
7. [Digestive and extra-digestive complications of nonsteroidal anti-inflammatory drugs. Preventive and curative strategies].
Sternon J; Adler M
Rev Med Brux; 1997 Apr; 18(2):52-8. PubMed ID: 9221462
[TBL] [Abstract][Full Text] [Related]
8. [Experience of treatment of patients with gastropathy induced by non-steroid anti-inflammatory drugs].
Vakhrushev IaM; Loshchakova OIu
Eksp Klin Gastroenterol; 2007; (1):60-3, 71. PubMed ID: 17547116
[TBL] [Abstract][Full Text] [Related]
9. The cost-effectiveness of misoprostol in preventing serious gastrointestinal events associated with the use of nonsteroidal antiinflammatory drugs.
Maetzel A; Ferraz MB; Bombardier C
Arthritis Rheum; 1998 Jan; 41(1):16-25. PubMed ID: 9433865
[TBL] [Abstract][Full Text] [Related]
10. Review article: prevention of non-steroidal anti-inflammatory drug gastrointestinal complications--review and recommendations based on risk assessment.
Chan FK; Graham DY
Aliment Pharmacol Ther; 2004 May; 19(10):1051-61. PubMed ID: 15142194
[TBL] [Abstract][Full Text] [Related]
11. [The role of anti-ulcerative drugs in treatment and prevention of gastropathies induced by nonsteroidal anti-inflammatory drugs].
Fialová P; Vlcek J
Vnitr Lek; 2004 Nov; 50(11):858-66. PubMed ID: 15648967
[TBL] [Abstract][Full Text] [Related]
12. [Secondary and primary prophylaxis of gastropathy associated with nonsteroidal antiinflammatory drugs or low-dose-aspirin: a review based on four clinical scenarios].
Limmer S; Ittel TH; Wietholtz H
Z Gastroenterol; 2003 Aug; 41(8):719-28. PubMed ID: 12910426
[TBL] [Abstract][Full Text] [Related]
13. Eradication of Helicobacter pylori does not reduce the incidence of gastroduodenal ulcers in patients on long-term NSAID treatment: double-blind, randomized, placebo-controlled trial.
de Leest HT; Steen KS; Lems WF; Bijlsma JW; van de Laar MA; Huisman AM; Vonkeman HE; Houben HH; Kadir SW; Kostense PJ; van Tulder MW; Kuipers EJ; Boers M; Dijkmans BA
Helicobacter; 2007 Oct; 12(5):477-85. PubMed ID: 17760715
[TBL] [Abstract][Full Text] [Related]
14. Therapies for ulcers associated with nonsteroidal antiinflammatory drugs.
Chan FK; Sung JJ
N Engl J Med; 1998 Jul; 339(5):349-50; author reply 350-1. PubMed ID: 9696650
[No Abstract] [Full Text] [Related]
15. [Diagnostics and treatment of helicobacter infection. Treatment recommendation from Finnish Gastroenterological Association].
Suomen Gastroenterologiyhdistys
Duodecim; 2000; 116(5):548-60. PubMed ID: 11787107
[No Abstract] [Full Text] [Related]
16. Helicobacter pylori and nonsteroidal anti-inflammatory drug interactions in bleeding ulcers.
Radaelli F; Minoli G
Gastrointest Endosc; 2002 Oct; 56(4):604-6; discussion 606-7. PubMed ID: 12375565
[No Abstract] [Full Text] [Related]
17. Pretreatment antimicrobial susceptibility testing is cost saving in the eradication of Helicobacter pylori.
Romano M; Marmo R; Cuomo A; De Simone T; Mucherino C; Iovene MR; Montella F; Tufano MA; Del Vecchio Blanco C; Nardone G
Clin Gastroenterol Hepatol; 2003 Jul; 1(4):273-8. PubMed ID: 15017668
[TBL] [Abstract][Full Text] [Related]
18. Pharmacoeconomics in HP-related diseases: more questions than answers.
Deltenre M; De Bruyne I; Jonas C; De Koster E
Acta Gastroenterol Belg; 1998; 61(3):352-6. PubMed ID: 9795472
[No Abstract] [Full Text] [Related]
19. Therapies for ulcers associated with nonsteroidal antiinflammatory drugs.
Guslandi M
N Engl J Med; 1998 Jul; 339(5):350; author reply 350-1. PubMed ID: 9696651
[No Abstract] [Full Text] [Related]
20. [What is the current therapeutic role of omeprazole in gastroduodenal ulcer disease?].
Gisbert JP; Boixeda D; Martín de Argila C
Rev Esp Enferm Dig; 1997 Feb; 89(2):116-23. PubMed ID: 9115818
[No Abstract] [Full Text] [Related]
[Next] [New Search]
